BRIEF-Serina Therapeutics Says US FDA Places Clinical Hold On SER-252 Program

Reuters

Nov 03, 2025

BRIEF-Serina <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Says US FDA Places Clinical Hold On SER-252 Program

Nov 3 (Reuters) - Serina Therapeutics Inc SER.A:

SERINA THERAPEUTICS PROVIDES REGULATORY UPDATE ON SER-252 PROGRAM
SERINA THERAPEUTICS INC - FDA PLACES CLINICAL HOLD ON SERINA'S SER-252 IND APPLICATION
SERINA THERAPEUTICS INC - FDA REQUESTS ADDITIONAL INFORMATION ON EXCIPIENT IN FORMULATION
SERINA THERAPEUTICS INC - EXPECTS FDA'S FORMAL CLINICAL-HOLD LETTER WITHIN 30 DAYS

Source text: ID:nGNX7LN5Bs

Further company coverage: SER.A

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2580292583"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2580292583\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2580292583?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-03 19:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2580292583","market":"us","top_or_hot":-1,"title":"BRIEF-Serina Therapeutics Says US FDA Places Clinical Hold On SER-252 Program","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Serina <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Says US FDA Places Clinical Hold On SER-252 Program</title></head><body><p><span>Nov 3 (Reuters)</span><span> - </span>Serina Therapeutics Inc <span>SER.A</span>:</p><ul><li><p>SERINA THERAPEUTICS PROVIDES REGULATORY UPDATE ON SER-252 PROGRAM</p></li><li><p>SERINA THERAPEUTICS INC - FDA PLACES CLINICAL HOLD ON SERINA'S SER-252 IND APPLICATION</p></li><li><p>SERINA THERAPEUTICS INC - FDA REQUESTS ADDITIONAL INFORMATION ON EXCIPIENT IN FORMULATION</p></li><li><p>SERINA THERAPEUTICS INC - EXPECTS FDA'S FORMAL CLINICAL-HOLD LETTER WITHIN 30 DAYS</p></li></ul><p>Source text: <span>ID:nGNX7LN5Bs</span></p><p>Further company coverage: <span>SER.A</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Serina Therapeutics Says US FDA Places Clinical Hold On SER-252 Program</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Serina Therapeutics Says US FDA Places Clinical Hold On SER-252 Program\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-03 19:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Serina <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Says US FDA Places Clinical Hold On SER-252 Program</title></head><body><p><span>Nov 3 (Reuters)</span><span> - </span>Serina Therapeutics Inc <span>SER.A</span>:</p><ul><li><p>SERINA THERAPEUTICS PROVIDES REGULATORY UPDATE ON SER-252 PROGRAM</p></li><li><p>SERINA THERAPEUTICS INC - FDA PLACES CLINICAL HOLD ON SERINA'S SER-252 IND APPLICATION</p></li><li><p>SERINA THERAPEUTICS INC - FDA REQUESTS ADDITIONAL INFORMATION ON EXCIPIENT IN FORMULATION</p></li><li><p>SERINA THERAPEUTICS INC - EXPECTS FDA'S FORMAL CLINICAL-HOLD LETTER WITHIN 30 DAYS</p></li></ul><p>Source text: <span>ID:nGNX7LN5Bs</span></p><p>Further company coverage: <span>SER.A</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SER","symbol_name":"Serina Therapeutics, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUA365RJN:1","article_id":"2580292583","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2580292583","pubTimestamp":1762170270,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Serina Therapeutics Says US FDA Places Clinical Hold On SER-252 ProgramNov 3 (Reuters) - Serina Therapeutics Inc SER.A:SERINA THERAPEUTICS PROVIDES REGULATORY UPDATE ON SER-252 PROGRAMSERINA THE","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SER":"Serina Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"简介-Serina Therapeutics表示美国FDA暂停SER-252项目的临床","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SER":0.9},"content_text":"BRIEF-Serina Therapeutics Says US FDA Places Clinical Hold On SER-252 ProgramNov 3 (Reuters) - Serina Therapeutics Inc SER.A:SERINA THERAPEUTICS PROVIDES REGULATORY UPDATE ON SER-252 PROGRAMSERINA THERAPEUTICS INC - FDA PLACES CLINICAL HOLD ON SERINA'S SER-252 IND APPLICATIONSERINA THERAPEUTICS INC - FDA REQUESTS ADDITIONAL INFORMATION ON EXCIPIENT IN FORMULATIONSERINA THERAPEUTICS INC - EXPECTS FDA'S FORMAL CLINICAL-HOLD LETTER WITHIN 30 DAYSSource text: ID:nGNX7LN5BsFurther company coverage: SER.A ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}